Osaka

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• High blood pressure2 trials
• Amyloidosis1 trial
• Cytomegalovirus infection1 trial

Phase

• Phase 33 trials
• Phase 1/21 trial

Status

• Completed2 trials
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Alnylam Pharmaceuticals3 trials
• ModernaTX, Inc.1 trial

Running trials

• Recruiting

  Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  NCT07181109· Phase 3· Alnylam Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• High blood pressure1 recruiting

Closed trials

• Completed

  A Study to Evaluate Zilebesiran in Japanese Patients With Mild to Moderate Hypertension

  NCT06423352· Phase 1/2· Alnylam Pharmaceuticals· Source

• Terminated

  A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

  NCT05085366· Phase 3· ModernaTX, Inc.· Source

• Completed

  HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)

  NCT03759379· Phase 3· Alnylam Pharmaceuticals· Source